-
-
-
-
-
-
-
Novocure's TRIDENT trial misses primary endpoint in glioblastoma
-
-
-
-
-
-
-
NovoCure receives Japan reimbursement approval for lung cancer device
-
-
-
-
-
-
-
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
-
-
-
-
-
-
-
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
-
-
-
-
-
-
-
Novocure presents positive phase 3 trial results for brain metastases therapy
-
-
-
-
-
-
-
NovoCure submits FDA application for pancreatic cancer treatment
-
-
-
-
-
-
-
Novocure Announces Upcoming Investor Events
-
1,208,296 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

